Daniel V. LaBarbera

发表

Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties

Byong Hoon Yoo, P. Kabos, C. Sartorius, 2013, Hormones and Cancer.

3D High-Content Screening of Organoids for Drug Discovery

D. LaBarbera, L. Li, Daniel V. LaBarbera, 2017 .

High-throughput imaging: Focusing in on drug discovery in 3D.

Linfeng Li, Qiong Zhou, Ty C Voss, 2016, Methods.

Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21.

James R. Roede, John O. Marentette, D. LaBarbera, 2022, Free radical biology & medicine.

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer

N. Agarwal, D. Theodorescu, D. Arya, 2022, International journal of molecular sciences.

The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis

P. Suryanarayana, G. B. Reddy, J. M. Petrash, 2012, PloS one.

Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer

M. Ferrer, A. D’Alessandro, W. Messersmith, 2021, Oncogene.

Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells

C. Sartorius, S. Nordeen, D. LaBarbera, 2017, Oncogene.

3D Models of Epithelial-Mesenchymal Transition in Breast Cancer Metastasis

Mary Kay Harper, M. K. Harper, Qiong Zhou, 2011, Journal of biomolecular screening.

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes

J. Costello, D. Theodorescu, Qiong Zhou, 2022, International journal of molecular sciences.

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

E. Sokol, A. Tan, B. Haugen, 2018, Clinical Cancer Research.

Drug Design Targeting T-Cell Factor (TCF)-Driven Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Strategy for Colorectal Cancer.

A. D’Alessandro, W. Messersmith, J. Schaack, 2019, Journal of medicinal chemistry.

Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells.

J. M. Petrash, D. LaBarbera, Daniel V. LaBarbera, 2015, Chemico-biological interactions.

TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer

Robert T. Jones, T. Cech, D. Theodorescu, 2021, Proceedings of the National Academy of Sciences.

High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog)

M. Weiser-Evans, R. Nemenoff, K. Moulton, 2020, Arteriosclerosis, thrombosis, and vascular biology.

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

A. Tan, T. Pitts, W. Messersmith, 2020, Molecular Cancer Therapeutics.

Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.

W. Messersmith, U. Kompella, Qiong Zhou, 2022, Journal of medicinal chemistry.

Advanced High-Content-Screening Applications of Clonogenicity in Cancer

Qiong Zhou, D. LaBarbera, Daniel V. LaBarbera, 2020, SLAS discovery : advancing life sciences R & D.

Halogenated cyclic peptides isolated from the sponge Corticium sp.

M. K. Harper, C. Ireland, D. Laird, 2007, Journal of natural products.

The multicellular tumor spheroid model for high-throughput cancer drug discovery

Daniel V LaBarbera, Brian G Reid, Byong Hoon Yoo, 2012, Expert opinion on drug discovery.

Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer

F. Valeriote, J. Arcaroli, W. Messersmith, 2016, Oncogene.

Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition

R. Hromas, J. Nickoloff, Qiong Zhou, 2011, Marine drugs.

Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo

S. Sams, D. LaBarbera, P. Reigan, 2021, Molecular carcinogenesis.

Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.

J. M. Petrash, D. LaBarbera, D. Ammar, 2016, Journal of natural products.

Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.

J. M. Petrash, D. LaBarbera, Daniel V. LaBarbera, 2014, Investigative ophthalmology & visual science.

A High-Content Assay to Identify Small-Molecule Modulators of a Cancer Stem Cell Population in Luminal Breast Cancer

P. Kabos, C. Sartorius, J. Schaack, 2012, Journal of biomolecular screening.

3D Models of Epithelial-Mesenchymal Transition in Breast Cancer Metastasis

M. K. Harper, J. Schaack, Qiong Zhou, 2011, Journal of biomolecular screening.

Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri

A. Debnath, D. LaBarbera, Daniel V. LaBarbera, 2017, PLoS neglected tropical diseases.

Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.

Daniel V. LaBarbera, Jessica Ponder, J. Petrash, 2014, Investigative ophthalmology & visual science.

High-throughput imaging: Focusing in on drug discovery in 3D.

T. Voss, Qiong Zhou, Daniel V. LaBarbera, 2016, Methods.

Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery

P. Kabos, C. Sartorius, Qiong Zhou, 2014, Current chemical genomics and translational medicine.

Discovery of quinolinediones exhibiting a heat shock response and angiogenesis inhibition.

L. Whitesell, D. LaBarbera, C. L. David, 2008, Journal of medicinal chemistry.

The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells

M. K. Harper, N. Moghal, C. Ireland, 2009, Anti-cancer drugs.

Validation of ferroptosis in canine cancer cells to enable comparative oncology and translational medicine

D. Thamm, J. Eaton, Daniel V. LaBarbera, 2024, bioRxiv.

Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.

J. M. Petrash, D. LaBarbera, Daniel V. LaBarbera, 2014, Journal of medicinal chemistry.

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

C. Korch, J. Fagin, B. Haugen, 2019, Molecular Cancer Research.

SBI2 HCS/HCA 3D Imaging: Best Practices and Unmet Needs Colloquium.

Jan Seldin, Myles Fennell, Daniel V LaBarbera, 2017, Assay and drug development technologies.

Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment

Chaoping Chen, D. LaBarbera, Daniel V. LaBarbera, 2019, Scientific Reports.